SAF-Holland SE/ DE000SAFH001 /
10/05/2024 12:39:17 | Var. - | Volume | Denaro09:00:11 | Lettera09:00:11 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
16.92EUR | - | 231 Fatturato: 3,908.52 |
-Quantità in denaro: - | -Quantità in lettera: - | 768.07 mill.EUR | 5.02% | 9.61 |
GlobeNewswire
07:05
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
GlobeNewswire
07:05
Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
GlobeNewswire
07:00
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type ...
GlobeNewswire
07:00
Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with typ...
GlobeNewswire
07:00
Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024
GlobeNewswire
06:08
Sen. John Cornyn delivers remarks at Driscoll Children's Hospital Rio Grande Valley
GlobeNewswire
05:00
Flash News: OKX to List Ultiverse's Token on its Spot Market, Expanding Trading Options
GlobeNewswire
04:38
Avaada Energy Secures 1050 MWp Solar Project in NTPC Auction; Crosses over 15 GWp Portfolio in India
GlobeNewswire
03:41
United States Government to Reinstate Section 301 Import Tariffs on Artificial Graphite from China
GlobeNewswire
03:16
Lowey Dannenberg, P.C. is Investigating Akero Therapeutics, Inc. (“Akero”) (NASDAQ: AKRO) for Potent...
GlobeNewswire
03:00
ENPHASE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Agai...
GlobeNewswire
03:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Spr...
GlobeNewswire
03:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Int...